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Abstract
Background: It is currently unknown whether exergaming is efficacious in people with major neurocognitive
disorder (MNCD) residing in long-term care facilities. This pilot randomized controlled trial (RCT) explored the
efficacy of a stepping exergame program on gait speed, balance, mobility, reaction time, cognitive and
neuropsychiatric outcomes, quality of life, and daily life functioning in people with MNCD residing in long-term
care facilities.
Methods: Participants were randomly assigned to 8 weeks, three times weekly, 15 min of exergaming versus
watching preferred music videos. The exergame device consisted of a pressure-sensitive step training platform on
which participants performed stepping movements to play the games. The device automatically adapted the
training level to the participants’ capabilities. The Short Physical Performance Battery (SPPB), step reaction time test
(SRTT), Montréal Cognitive Assessment (MoCA), Neuropsychiatric Inventory (NPI), Cornell Scale for Depression in
Dementia (CSDD), Dementia Quality of Life (DQoL), and Katz Activities of Daily Living (Katz ADL) were assessed at
baseline and post-intervention. A Quade’s non-parametric ANCOVA controlling for baseline values with post hoc
Bonferroni correction (p < 0.00625) was used to analyze pre- and post-differences between the groups. Partial eta-
squared (η2p) effect sizes were calculated.
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Results: Forty-five of 55 randomized inpatients with mild to moderate MNCD (Mini-Mental State Examination
score = 17.2 ± 4.5; aged 70–91; 35 women) completed the study. The exergame group (n = 23) demonstrated
improvements in gait speed (p < 0.001, η2p = 0.41), total SPPB (p < 0.001, η2p = 0.64), SRTT (p<0.001, η2p = 0.51),
MoCA (p<0.001, η2p = 0.38), and reductions in CSDD (p<0.001, η2p = 0.43) compared to the control group (n = 22).
There were no differences in NPI (p = 0.165, η2p = 0.05), DQoL (p = 0.012, η2p = 0.16), and ADL (p = 0.008, η2p = 0.16)
post-intervention scores between the experimental and control group, albeit DQol and ADL measures showed
large effect sizes in the exergame group. The mean attendance rate was 82.9% in the exergame group and 73.7%
in the music control group. There were no study-related adverse events reported by the participants, nor observed
by the research team.
Conclusions: The findings of this pilot RCT suggest that an individually adapted exergame training improves lower
extremity functioning, cognitive functioning and step reaction time and symptoms of depression in inpatients with
MNCD residing in long-term care facilities.
Trial registration: ClinicalTrials.gov, NCT04436302
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Introduction
Major neurocognitive disorder (MNCD) is a syndrome
characterized by cognitive function impairment, motor
decline, and psychological and behavioral problems [1].
In 2019, there were worldwide over 50 million people
with MNCD. This number is estimated to increase to
152 million by 2050, predominantly driven by popula-
tion aging [2]. The progressive functional decline ob-
served in people with MNCD contributes to a reduced
quality of life, loss of independence, and increased care-
giver effort [3]. Higher levels of care often result in
transfers to long-term care facilities [4]. This is placing a
substantial burden on health care systems and has re-
sulted in MNCD being considered a public health prior-
ity by the World Health Organization [5].
No disease-modifying treatments, pharmacological
nor non-pharmacological, have been developed that
can cure MNCD or halt its progression [6]. Therefore,
the main goals of caring for people with MNCD admit-
ted to long-term care facilities are maintaining or
improving their physical condition and their mental
and physical quality of life. To this end, non-
pharmacological therapies targeting people’s lifestyle
are recommended as a first-line approach [7]. Potential
strategies to improve health and well-being of people
with MNCD in long-term care facilities include envir-
onment adaptation [8], sensory interventions, and phys-
ical activity [9]. Physical activity can delay the course of
the disease and thereby counteract the decline in func-
tionality [9, 10]. In addition, physical activity improves
gait speed, balance, mood, and execution of daily life
activities [9, 11]. Improvement in gait speed is particu-
larly relevant as slow gait speed is associated with an
increased risk of falls in people with MNCD [12], which
on its turn is associated with higher rates of co-
morbidity and premature mortality [13].
Despite the benefits, engaging people with MNCD res-
iding in long-term care facilities in physical activity is
often a challenge. Behavioral symptoms like agitation
and passivity which are exhibited by 90% of nursing
home residents with MNCD [14] and disorientation and
decreased interest [15] are the most important barriers.
The physical activity levels of residents decrease steadily
after admission to a long-term care facility [16] and
people with MNCD who are residing in a nursing home
environment remain physically inactive for most of the
day [8].
Innovative developments in technology have provided
new options to engage older adults with MNCD in an
enjoyable way through exergames [17]. Exergames com-
bine physical activity and cognitive tasks [18, 19] and
require the player to produce body movements in re-
sponse to visual, auditory, and somatosensory cues [20].
A recent qualitative study demonstrated that people with
MNCD residing in long-term care facilities enjoy exer-
gaming [21]. In this study, the mean attendance rate in
24 sessions during 8 weeks at three times per week was
79.3%. In recent years, a growing interest has emerged
as well in the efficacy of exergaming in people with
MNCD [15, 17, 22–24]. A previous meta-analysis dem-
onstrated that in residential and community-dwelling
older adults with mild cognitive impairment or MNCD,
a combination of cognitive and physical training resulted
in small-to-medium improvements in global cognitive
function and mood and moderate-to-large positive ef-
fects on activities of daily living [10]. A randomized con-
trolled trial in outpatients and community patients with
MNCD suggested that the group receiving combined
cognitive–aerobic bicycle exergame training during 30 to
50min at three times per week during 12 weeks and the
group receiving cycling at the same frequency, intensity,
and time without exergaming improved psychomotor
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speed [25] and reduced frailty [26], as compared to the
control group, receiving relaxation and flexibility exer-
cises. However, no differences were observed between
the three groups for executive functioning, episodic
memory and working memory [25, 26].
To the best of our knowledge, no randomized con-
trolled trial (RCT) has previously explored the efficacy
of a stepping exergame program on physical fitness
parameters including gait speed, mobility and balance,
step reaction time, neuropsychiatric symptoms, mood,
and quality of life in people with MNCD. Moreover,
it is currently unknown whether exergaming is also
efficacious in people with MNCD residing in long-
term care facilities. A qualitative study in people with
MNCD in long-term care facilities did show promis-
ing effects of exergaming on self-reported cognitive
functioning, activities of daily living performance, fear
of falls, quality of life, mood, and several physical out-
comes, such as gait speed, mobility, and balance [21].
However, these preliminary qualitative findings need
to be confirmed in a RCT.
Therefore, the goal of the current pilot RCT was to fill
these gaps in the literature by exploring the physical,
mental, and cognitive effects of an exergame program
added to care as usual as compared to a passive control
condition (i.e., watching preferred music videos) in
people with MNCD residing in long-term care facilities.
Methods
Participants and procedure
This pilot RCT was conducted following the Consoli-
dated Standards of Reporting Trials guidelines (CON-
SORT, Boutron et al., 2008; Cuschieri, 2019). The
CONSORT extensions for pilot abstract and pilot trials
were added in Additional file 1 [27]. The trial was regis-
tered in ClinicalTrials.gov (Identifier: NCT04436302).
Inpatients of the University Psychiatric Centre KUL in
Kortenberg and residents of long-term care facility de
Wingerd in Leuven (Vlaams Brabant, Belgium) diag-
nosed with MNCD were included. Participants were ran-
domly assigned by an independent statistician using a
random number generator (https://www.random.org/) to
either 8 weeks, three times per week 15 min of exergam-
ing (experimental group), added to care as usual, or
seated listening to favorite music (control group), at a
same volume, added to care as usual. Care as usual con-
sisted of pharmacotherapy and physiotherapy focusing
on comfort care. Participants were assessed at baseline
(pretest) and after 8 weeks (posttest) by a physiotherapist
blinded to group allocation using the Short Physical Per-
formance Battery (SPPB) in order to assess gait speed,
balance and lower limb strength [28, 29], a step reaction
time test, the Montréal Cognitive Assessment (MoCA)
[30–32], the Neuropsychiatric Inventory (NPI) [33], the
Cornell Scale for Depression in Dementia [34], the De-
mentia Quality of Life (DQoL) questionnaire [35, 36],
and Activities of Daily Living [37, 38]. The study proto-
col was approved by the Medical Ethics committee of
UZ Leuven (reference number S60641). All participants
and their legal representatives gave their written in-
formed consent. No compensation was granted to the
participants.
Power analysis
The principal outcome measure was gait speed. An
exergame training program including balance training
demonstrated that gait speed can be increased by 0.13 m
per second [39] and a meaningful change lies around
0.10–0.15 m per second [39–41]. Older adults in long-
term care in general exhibit on average a walking vel-
ocity of 0.475 m per second based on the SPPB [42]. In
older adults in long-term care, a sample size of 12 par-
ticipants per group enables detection of a within-group
difference, from baseline to post-test, of 0.105 m per
second (SD = 0.16) on gait speed when a medium-sized
effect is expected [43, 44]. However, we decided to fol-
low the guidelines of Whitehead et al., who recommend
a sample size of at least 16 but ideally 26 participants
per group for a medium effect size in pilot trials [45]. To
account for attrition over time, 15% can be expected
with RCTs of exercise programs in long-term care
facilities [46]. The required a-priori sample size was in-
creased by 20% to minimum 20 but ideally 30 partici-
pants per group.
Eligibility criteria
Inclusion criteria were as follows: (a) a Diagnostic and
Statistical Manual of Mental Disorders (DSM) 5 diagno-
sis of MNCD (American Psychiatric Association, 2013),
(b) aged 65 years or older, (c) a score of minimum 10 on
the Mini-Mental State Examination (MMSE) [47] as
assessed by the research team, (d) having been residing
at least two weeks in the care facility at the time of in-
clusion and with a perspective of at least 10 more weeks
of stay, (e) and being physically capable of doing stand-
ing exercises (whether or not with extra support).
Possible causes of MNCD were vascular dementia, Alz-
heimer’s disease, mixed dementia, Parkinson’s disease,
frontotemporal degeneration, or Lewy body disease, as
diagnosed by the treating psychiatrist. Exclusion criteria
consisted of the following: (a) any unstable cardiovascu-
lar or other health condition which, according to the
American College of Sports Medicine Standards, might
lead to unsafe participation, (b) a score lower than 10 on
the MMSE, and (c) a planned transfer to another setting
within the following 2 months.
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Experimental condition
Participants performed three individual sessions per
week for a period of 8 weeks, resulting in a total of max-
imum 24 sessions. Each session consisted of a walk to
the exercise room (i.e., approximately 10 min), 15 min of
exergaming, and a walk back to the ward. The duration
of exergaming in previous research varied from 10min
[48, 49] up to 60 min [50]. A duration of 15 min was ex-
pected to be feasible and not too demanding for this
specific population. The exergame device “Dividat
Senso” (Dividat, Schindellegi, Switzerland) was adminis-
tered. This device consisted of a step training platform
(1.13 m × 1.13 m) which was sensitive to pressure
changes (strain gauges measuring at 50 Hz). The sensors
detected steps in four directions: left, right, top, and bot-
tom. Participants could grasp the bars on waist height,
when deemed necessary. Participants that used a wheel-
chair were assisted by the guiding therapist to stand up
and walk to the Dividat Senso exergame device. The
platform was connected via a USB cable to a computer
and a frontal television screen (LG, 94.5 cm × 53 cm,
model 43LJ500V, 43 in.) on which the exergames were
displayed. A picture of the Dividat Senso exergame de-
vice can be found in Fig. 1. The starting position was an
upright stance with both feet in the middle of the plat-
form. Participants interacted with the game interface by
pushing one foot on one of the four different arrows.
When the game required the player to perform a step to
the left or right, the associated lower limb was used. For
a step in the two other directions, the player used a
lower limb of preference. The games trained the follow-
ing cognitive abilities: divided and selective attention,
flexibility, postural control, and visuospatial working
memory. The device provided real-time visual, auditory
and somatosensory (vibrating platform) cues, and feed-
back in order to enrich the game experience. The ses-
sions consisted of multiple games and the duration of
each video game varied between 120 and 200 s. The fol-
lowing training principles [51] were implemented: (a)
task difficulty was individually adapted to facilitate reten-
tion, (b) training variability was provided in order to en-
hance task transfer, (c) a system of feedback to improve
Fig. 1 Dividat Senso exergame device. Permission was obtained from the copyright holder. Picture from the website dividat.com
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training effects, and (d) individual difficulty zones to
match the training level of each participant. The physical
therapist designed an individual program for each par-
ticipant, adapted to the participants’ functionality, cogni-
tion, and health status. The exergames automatically
adapted to the participants’ capabilities during active
exergaming, i.e., providing more difficult stimuli when
the players reacted fast and correct. During the 8-week
program, progress was also made regarding the reduc-
tion of manual support via the bars. All participants
were individually supervised to ensure safety and
comfort. A Template for Intervention Description and
Replication (TIDieR) checklist [52] was added in
Additional file 2. Also, a description of the specific
games and their characteristics are included in
Additional file 3.
Control condition
Participants watched and listened 15min, three times
per week for 8 weeks to preferred music videos on a
television screen (LG, 94.5 cm × 53 cm, model 43LJ500V,
43 in.) in the same exercise room. Each session consisted
of a walk to the exercise room (i.e., approximately 10
min), 15 min of watching and listening to music videos,
and a walk back to the ward. All participants were indi-
vidually supervised to promote comfort and personal
interaction with the therapist, who was the same person
as the therapist in the experimental condition. Listening
to music is a non-aerobic intervention which is recom-
mended in people with MNCD [53].
Outcome measures
Short Physical Performance Battery (SPPB)
Gait speed, balance, and lower limb strength were
assessed with the SPPB [28, 29]. It is composed of three
subtests; a hierarchical standing balance test, a short 4-
m walk at usual pace [54], and 5 chair rises. The max-
imal total score is 12 and higher total scores indicate a
better lower extremity functioning. Total scores between
10 and 12 indicate good functioning and no risk of de-
veloping mobility disability, total scores between 4 and 9
indicate an elevated risk, and scores between 0 and 3 in-
dicate an already present loss of mobility. The minimal
detectable change (MDC) of our primary outcome, gait
speed, on the 4-m walk test is 0.28 m per second [55].
Although researchers have previously expressed con-
cerns regarding the feasibility and validity of quantitative
functional assessments in people with MNCD [56, 57],
the reliability of the SPPB is high in older adults with
and without MNCD, with intraclass correlation coeffi-
cient (ICC) values ranging between 0.82 and 0.92 [55,
58, 59]. Test instructions were concise and repeated
when needed, and tasks were presented by the guiding
therapist [56]. Participants were allowed to use their as-
sistive devices such as a walker or a walking cane.
Step reaction time test (SRTT)
Average choice step reaction time for all four directions
together was assessed by means of the “Simple” protocol
of the Dividat Senso device. Four white circles were dis-
played on the television screen. These circles corre-
sponded to the four arrows on the step platform (up,
down, left, and right). The step direction was indicated
by one of the four circles turning red. Participants were
instructed to step as quickly as possible onto the corre-
sponding arrow of the step platform and to return to the
center. The program was designed so that the number
of stimuli and the speed at which the stimuli were pre-
sented accelerated in line with game performance. In
other words, the game adapted to the individuals’ per-
formance and was therefore not standardized. Choice
step reaction time was measured from stimulus occur-
rence to step finalization and was expressed in
milliseconds.
Although this test has not been psychometrically ex-
amined, choice reaction time tests have been developed
and examined in the past. A simple test for unplanned
volitional steps has excellent predictive validity for future
falls, good inter-day test-retest reliability (ICC 0.74) and
excellent criterion validity with a strong bivariate correl-
ation between a simple “low-tech” choice stepping reac-
tion time test and the electronic version of the choice
stepping reaction time test (r = 0.81, p < 0.001) [60, 61].
Montréal Cognitive Assessment (MoCA)
The MoCA, which is designed for milder forms of
MNCD, assesses memory, language, executive functions,
visuospatial skills, attention, concentration, abstraction,
calculation, and orientation using a paper and pencil
test. The MoCA has a good construct validity (r values
range from 0.46 to 0.75) [62], inter-rater reliability (r =
0.97), test-retest reliability (r = 0.88), and internal
consistency (Cronbach’s alpha = 0.89) [63]. We used the
total score (ranging from 0 to 30) with higher scores in-
dicating better cognitive functioning.
Neuropsychiatric Inventory (NPI)
Psychopathological problems were assessed with the NPI
[33]. It was administered in a semi-structured interview
setting with a close caregiver. One screening question
per behavior domain was asked to the caregiver, after
which approximately seven in-depth questions were pos-
sible. The behavior domains are delusions, apathy, hallu-
cinations, disinhibition, agitation/aggression, irritability,
depression/dysphoria, aberrant motor behavior, anxiety,
nighttime behavior disturbances, euphoria, and appetite
and eating abnormalities. Behavior frequency is scored
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on a 4-point scale, ranging from 1 to 4. Symptom sever-
ity is scored on a 3-point scale ranging from 1 to 3. The
NPI total score is calculated by multiplying the fre-
quency and severity rates per domain and adding them
up. The total score ranges from 0 to 144. The test–retest
reliability is 0.79 for behavior frequency (P = 0.0001) and
0.86 for symptom severity (P = 0.0001) [64]. The Cron-
bach’s alpha coefficient for the overall score is 0.88 [65].
Cornell Scale for Depression in Dementia (CSDD)
Symptoms of depression were assessed with the
observation-based CSDD, in the form of an interview
with the caregiver. The CSDD consists of 19 items and
each one is scored on a 3-point scale ranging from 0 to
2 [34]. Items are clustered into five categories: mood, be-
havioral disturbance, physical signs, cyclic functions, and
ideational disturbance. The CSDD has adequate internal
consistency and reliability in an older, frail nursing home
population with MNCD. Cronbach’s alpha is 0.81 and
the kappa values of two studies included are 0.57 and
0.91 [66].
Dementia Quality of Life (DQoL) questionnaire
Quality of life was assessed with the DQoL questionnaire
[36], which is widely used in clinical practice. It consists
of 29 items, measuring five domains: self-esteem (4
items), positive affect (6 items), negative affect (11
items), feelings of belonging (3 items), and sense of es-
thetics (5 items). A higher score per domain reflects bet-
ter QoL, except on the negative affect dimension.
Cronbach’s alpha coefficient for internal consistency
ranges from 0.71 to 0.84. The ICC for test-retest reliabil-
ity ranges from 0.69 to 0.80 [35].
Activities of Daily Living
The interviewer-administered Katz ADL Index [38] was
used to evaluate participants’ function in terms of level
of independence or dependence when performing cer-
tain daily living activities. It consists of six items: bath-
ing, dressing, transfers, toileting, continence, and
feeding. Each item is scored from 1 (independent) to 4
(dependent). The internal consistency of the Katz ADL
Index is good with a Cronbach’s alpha of 0.96, despite
the existence of cognitive decline [67].
Secondary outcomes
Secondary outcome measures were attendance and ad-
herence rates. Attendance sheets were completed during
each session to record the number of training sessions.
Attendance rates were measured by dividing the number
of attended training sessions by the maximum possible
number of training sessions (24 sessions). An attendance
rate of 70% or higher (minimum 17 attended out of 24
planned sessions) was deemed as being adherent to the
exergame program [68]. The adherence rate was deter-
mined by calculating the dropouts (attrition) as a per-
centage of the entire sample size. Participants signed an
informed consent stating that they were not obliged to
give a reason for non-attendance or drop-out. Therefore,
it was not possible to calculate reasons for non-
attendance.
Statistical analysis
Data were screened for normality using the Shapiro-
Wilk test. Since outcome data were not normally distrib-
uted, the between-group post-outcome differences were
analyzed with Quade’s non-parametric analysis of covari-
ance (ANCOVA). Although there were no significant
differences in baseline values between the experimental
and control group, we corrected for the baseline values.
However, in order to be able to compare the outcome
data with other studies, data are presented as mean ±
standard deviation. Imputation methods for missing data
were not applied given evidence of the subsequent risk
of bias [69]. Partial eta-squared (η2p) effect sizes were
calculated where a η2p of 0.01 to < 0.06 was considered
small, 0.06 to < 0.14 medium, and 0.14 or higher consid-
ered as a large effect size [70]. We corrected for multiple
testing. The Bonferroni-corrected statistical significance
level was set at P < 0.00625 (0.05/8 comparisons). Differ-
ences in demographic characteristics between the ex-
perimental and control groups were tested using the
Mann-Whitney U test. Differences in categorical vari-
ables were tested using Fisher’s exact test. Data were an-
alyzed with SPSS Version 26 (Armonk, NY, USA, 2017).
Results
Participants
A total of 114 participants were assessed for eligibility,
of which 44 failed to meet the inclusion criteria. Another
15 people refused to participate. Of this group, 4 (26.7%)
did not give a specific reason, ten (66.7%) were not inter-
ested, and one (6.7%) performed the training program
but withdrew consent following the intervention. Finally,
45 participants (11 from the University Psychiatric
Centre KUL and 34 from long-term care facility de Win-
gerd) consented to participate in this study and were
randomly assigned to either the exergame intervention
(n = 28) or music control group (n = 27). Five subjects
dropped out due to transfer to another setting. Another
five were excluded as the study ended prematurely due
to COVID-19 measures. In total, 23 participants in the
exergame group and 22 in the control group completed
the study. The flow chart is illustrated in Fig. 2.
A more detailed description of the participants’ indi-
vidual characteristics is provided in Table 1. Thirty-five
women (77.8%) and 10 men (22.2%) were included, with
a mean age of 85.0 (SD = 6.0) and mean MMSE score of
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Fig. 2 CONSORT diagram of participant flow
Table 1 Participant characteristics
Variables Sub-category Exergame group (n = 23) Music group (n = 22) pa
Age in years, mean (SD) 84.7 (5.6) 85.3 (6.5) 0.224
Gender, n (%) Male 5 (21.7) 5 (22.7) > 0.999
Female 18 (78.3) 17 (77.3) > 0.999
MMSE, mean (SD)b 18 (4.4) 17 (4.2) 0.102
Diagnosis, n (%) Alzheimer’s disease 17 (73.9) 14 (63.6) 0.530
Vascular dementia 2 (8.7) 4 (18.2) 0.414
Mixed Alzheimer’s and vascular dementia 2 (8.7) 3 (13.6) 0.665
Frontotemporal Degeneration 0 (0) 1 (4.5) 0.489
Lewy body disease 0 (0) 0 (0) > 0.999
Neurocognitive disorder not otherwise specified 2 (8.7) 0 (0) 0.489
Somatic comorbidities, n (%) Diabetes type II 2 (8.7) 5 (22.7) 0.243
Heart disease 8 (34.8) 11 (50.0) 0.375
Hypertension 4 (17.4) 0 (0) 0.109
Gait disorders 12 (52.2) 14 (63.6) 0.550
Visual deficiencies (cataract, glaucoma) 3 (13.0) 0 (0) 0.233
Indoor mobility, n (%) Wheelchair 2 (8.7) 0 (0) 0.49
4-wheeled walker 3 (13.0) 4 (18.2) 0.70
Single-point walking cane 0 (0) 2 (9.1) 0.23
No walking aid 18 (78.3) 16 (72.7) 0.74
Attendance rates (%) 82.9 73.7 0.07
ap values of group comparisons refer to Mann-Whitney U tests for continuous variables and Fisher’s exact tests for categorical variables
bScores on the MMSE range from 0 (severe impairment) to 30 (no impairment)
MMSE Mini-Mental State Examination
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17.2 (SD = 4.5). Information on diagnosis and somatic
comorbidities were taken from patient charts. Eleven
participants (24.4%) used an assistive walking device.
There was no difference in age between both groups
(p = 0.224) nor a difference in gender distribution (p =
0.609) or baseline MMSE (p = 0.102).
Effects of exergame intervention
The means and standard deviations of the pretest and post-
test battery scores for the intervention and control groups
and the P values, F values, and partial eta squared (η2p) are
depicted in Table 2. The medians and interquartile ranges
can be found in Additional file 4: Supplementary Table 1.
Compared to the control group, the exergaming group had
significantly better gait speed after the intervention (p <
0.001, η2p = 0.410). Significantly more participants in the
exergame group improved beyond the minimal clinical de-
tectable change on gait speed than participants in the music
control condition (47.8% vs. 0%, p < 0.001). Participants in
the exergame group also had an overall better lower ex-
tremity functioning as assessed with the SPPB (η2p = 0.643,
p < 0.001) post-intervention. SRTT scores (η2p = 0.506, p <
0.001) and MoCA scores (η2p = 0.385, p = < 0.001) also im-
proved significantly after 8 weeks of exergame training. In
addition, CSDD scores improved significantly after 8 weeks
of exergame training (η2p = 0.431, p < 0.001). There were
no significant differences in NPI (η2p = 0.051, p = 0.165),
DQoL (η2p = 0.157, p = 0.012) and ADL (η
2
p = 0.161, p =
0.008) post-intervention scores between the experimental
and control group, albeit DQoL and ADL measures showed
large effect sizes.
Attendance, adherence, and safety
The mean attendance rate was 82.9% (SD = 13.14) in the
exergame intervention group and 73.7% (SD = 25.20) in
the music control group. None of the attended sessions,
both in the exergame and in the music condition, had to
be stopped prematurely. Nineteen participants in the
exergame intervention group and 13 participants in the
music control group reached an attendance rate of at
least 70% of the sessions, which was deemed as being
adherent to the exergame program [68]. The self-
reported training intensity varied from mild to moderate.
There were no study-related adverse events reported by
the participants, nor observed by the research team.
Discussion
To the best of our knowledge, this is the first RCT to in-
vestigate the physical, mental, and cognitive effects of
8 weeks of stepping exergame training, added to care as
usual, in institutionalized people with MNCD. Com-
pared to adding non-aerobic music video listening and
watching (for a duration of 8 weeks, three times per
week for 15 min), involvement in stepping exergame
training (three times per week for 15 min during 8 weeks)
in addition to care as usual significantly improved gait
speed, mobility, and balance as measured with the SPPB,
step reaction time as measured with the SRTT, and cog-
nitive function as measured with the MoCA. In addition,
symptoms of depression, as measured with the CSDD,
were significantly reduced in the latter group. No signifi-
cant effects were found on neuropsychiatric symptoms
as measured with the NPI, quality of life as measured
with the DQoL questionnaire, and ADL functioning as
assessed with the Katz ADL Index, albeit DQoL and
ADL measures showed large effect sizes.
Our finding that exergaming improved lower extrem-
ity functioning is in contrast with previous cognitive-
aerobic bicycle training trials in community-dwelling
Table 2 The effects of an exergame intervention and a music intervention on measured outcomes
Variable Intervention (n = 23) Control (n = 22) P F η2p
Pre test (mean ± SD) Post test (mean ± SD) Pre test (mean ± SD) Post test (mean ± SD)
SPPB 5.5 ± 1.9 8.5 ± 2.5 5.2 ± 2.9 3.8 ± 2.5 < 0.001* 72.1 0.64
Gait speed (m/s) 0.6 ± 0.2 0.8 ± 0.3 0.6 ± 0.2 0.5 ± 0.2 < 0.001* 29.3 0.41
SRTT (ms) 2827.1 ± 1884.1 1426.6 ± 333.1 4551.1 ± 4243.6 5292.9 ± 4893.4 < 0.001* 38.8 0.51
MoCA 9.4 ± 4.1 12.1 ± 5.2 8.5 ± 5.2 5.7 ± 4.0 < 0.001* 24.4 0.38
NPI 11.4 ± 12.8 6.6 ± 11.4 8.4 ± 7.4 16.1 ± 15.1 0.165 2.0 0.05
CSDD 7.0 ± 6.4 3.0 ± 4.4 5.3 ± 4.5 9.3 ± 6.7 < 0.001* 28.8 0.43
DQoL 2.7 ± 0.7 3.5 ± 0.9 3.0 ± 0.9 3.0 ± 0.9 0.012 6.9 0.16
ADL 9.0 ± 2.1 9.0 ± 2.3 10.1 ± 2.8 11.4 ± 3.4 0.008 7.7 0.16
*Significant when P < 0.00625 (0.05/8 comparisons) using Quade’s non-parametric analyses of covariance with post test scores as dependent variables, groups as
independent variables, and baseline scores as covariates. ADL, activities of daily living (range = 6 to 24 with higher scores indicating higher dependency in
activities of daily living); CSDD, Cornell scale for depression in dementia (range = 0 to 38, and a score below 6 is associated with absence of depressive symptoms,
and scores above 10 indicate probable major depression); DQoL, Dementia Quality of Life (scores range from 1 (poor QoL) to 5 (excellent QoL)); MoCA, Montréal
Cognitive Assessment (total scores range from 0 to 30 with lower scores indicating more cognitive impairment); NPI, Neuropsychiatric Inventory (12-item score
with a range of 0 to 12 per item); SPPB, Short Physical Performance Battery (total scores range from 0 to 12 with lower scores indicating a higher risk and a score
lower than 10 indicates one or more mobility limitations); SRTT, step reaction time test (lower values indicate a faster reaction time)
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people with mild MNCD [25, 71]. A possible reason for
the difference with previous bicycle training research is
that our participants performed standing balance exer-
games that required participants to stand and perform
stepping movements, which directly addresses gait and
balance [72]. The exergame we used utilized a changing
base of support required to play the games which better
meets the specifics for training postural control [73] as
compared to sitting on a stationary bicycle. The con-
trasting findings may also be explained by the spatial
versus non-spatial processing demands in combination
with the postural modality of the exercises [74]. Whereas
exercising in an upright body position enhances both
processing speed and attentional selectivity [75], such ef-
fects are not observed for exercise performed pedaling a
bicycle in a seated position, indicating that body posture
during exercise has a dynamic influence on visual work-
ing memory performance [74]. A previous pilot study in-
vestigating a Wii-Fit program and walking program,
both performed for 30 min daily, five times a week for
8 weeks by participants with mild Alzheimer’s disease
living in an assisted living facility, also resulted in com-
parable improvements in gait and balance in both
groups, as measured by the Berg Balance Scale and the
Tinetti test [76]. Similarly, an eight-week home-based
Wii-Fit training for 30 min daily, five times a week in
community-dwelling people with mild Alzheimer’s dis-
ease resulted in improvements in BBS scores, which
were sustained after 16 weeks of follow-up, as compared
to a walking group with comparable training duration
[77]. The observed improvements in SPPB scores in the
present study are considered of high clinical relevance as
low scores on the SPPB including a low gait speed are
highly predictive of health-related consequences, such as
mobility impairment [78], future hospitalization [79],
longer hospitalization duration [80], admission to long-
term care facilities, premature mortality [28, 81], and
falls [82]. Improved gait speed is also known to be asso-
ciated with a faster step reaction time, and both an im-
proved gait speed and faster step reaction time are
associated with a reduced fall risk [12, 54]. The current
findings do show that exergaming improves the step re-
action time significantly as well. It should however be
noted that the modality of the SRTT was similar to one
of the exergames. A learning effect therefore cannot be
excluded in the intervention group compared to the
control group.
Besides improvements in physical parameters, cogni-
tive functioning, as assessed with the MoCA, amelio-
rated. These findings are in line with a previous meta-
analysis of RCTs demonstrating that in older adults with
MCI or MNCD, a combined cognitive-physical training
program leads to small-to-medium improvements in
cognitive function [10].
A final important observation was that our exergaming
program induced significant reductions in depression, as
measured with the CSDD following exergaming versus
music video listening and watching. A recent systematic
review of exergames in older adults found these inter-
ventions to be generally effective for reducing depres-
sion, particularly in older adults with high depressive
symptoms [83].
Despite improvements in QoL, these changes were
not significantly different from the control condition.
A reason might be that music interventions are
known to improve QoL in this population [53]. An-
other reason might be that we investigated individual
exergame training. Previous research in people with
MNCD showed that in particular exergaming in a
group improves QoL [84].
Although not significant, we observed large effect sizes
for improvements in ADL. The lack of significant im-
provements in ADL is in line with a study examining the
effects of a Nintendo-Wii bowling game in residents of
retirement homes with and without MNCD [50]. In a
more recent RCT, no improvements in Katz ADL were
found after 12 weeks of cognitive-aerobic bicycle training
on a stationary bike in community-dwelling older adults
with MNCD [26]. The findings in our study and previ-
ous RCTs in MNCD are, however, not consistent with a
meta-analysis exploring the efficacy of combined
cognitive-physical training in older adults with MCI or
MNCD that demonstrated moderate-to-large positive ef-
fects on activities of daily living [10]. However, this
meta-analysis also included people with MCI with less
severe ADL impairments, which limits comparability
with our results.
A strength of the study is that we also included older
adults with MNCD using canes, walkers, and wheel-
chairs. Therefore, our findings are generalizable to
mobility-impaired people with MNCD. All participants
were able to acquire and retain motor skills in the exer-
game environment. The notable adherence rates and ab-
sence of reported adverse events are additional strong
features of our intervention. These findings suggest that
individual exergame sessions, supervised one on one by
a physical therapist, are feasible and efficacious in this
vulnerable population.
Future research using an exergame approach is war-
ranted and should explore the underlying mechanisms
of the observed benefits. For example, it is known that
exercise leads to elevated levels of brain-derived neuro-
trophic factor, which supports the growth and mainten-
ance of neurons. Hippocampal structure and function
are altered by exercise and memory and cognitive func-
tion are facilitated [85]. It is also possible that the ob-
served improvements in executive functions in our study
might be due to modulations in prefrontal cortex
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oxygenation [86] or to the reorganization of neuronal
networks [87]. However, larger trials are needed to in-
vestigate these mechanisms in more detail. Moreover,
there is increasing evidence that the combination of
physical and cognitive activity may have synergistic ef-
fects [88, 89]. While physical exercise facilitates plasti-
city, cognitive activity guides the plastic changes [90].
Future research could, for example, compare the effects
and dose-response of exergaming versus aerobic and/or
strength training and/or balance training on physical,
mental, and cognitive outcomes and underlying mecha-
nisms in people with MNCD. Other opportunities for
future research include further exploration of the phys-
ical, mental, and cognitive effects of exergaming using
mixed methods randomized controlled designs where
the quantitative outcomes can be enriched by the partic-
ipants’ subjective perceptions. Future research should
explore the efficacy of exergaming on gait and balance
outcomes to explore possible exercise interventions for
this population. Long-term follow-up of the effects of
exergame training on the examined outcomes is war-
ranted to explore possible maintenance effects. Further-
more, incidence of falls, fall-related injuries, and fall
efficacy should also be explored, in particular since it
has been demonstrated that step training can prevent
falls by 50% in older adults in both community and insti-
tutional settings [91]. Large scale RCTs should also ex-
plore whether the beneficial effects might differ between
different diagnoses of MNCD and between different
levels of MNCD severity and could investigate differ-
ences in outcomes between individual training versus
group training interventions. Finally, implementation re-
search is needed to explore the (cost-)effectiveness of
exergaming in people with MNCD in psychiatric and
residential care. Such trials are ongoing [92].
Limitations
Although very promising, the findings of the current
RCT need to be interpreted with caution due to some
limitations. First, this was a pilot RCT exploring the effi-
cacy of exergaming in a wide range of physical, cogni-
tive, and mental parameters in people with MNCD
residing in residential care settings. Although our pilot
trial had sufficient power, larger trials comparing exer-
gaming with other active control interventions such as
aerobic exercise need to confirm or refute our prelimin-
ary findings. Second, our study was limited to solely two
care institutes in one geographical area in Belgium
which limits generalizability to other settings and coun-
tries. Third, since only inpatients who were motivated to
participate in the exergame program were enrolled, the
current findings might not be generalizable to all institu-
tionalized older adults with MNCD. Fourth, due to the
nature of the exergame which adapts the training
stimulus to the individual level of the participant, we did
not evaluate a standardized protocol that would have
allowed us to explore a dose-response relation in a more
rigorous way. The observed training intensities varied
from mild to moderate. Fifth, women were over-
represented (77.8%). This over-representation is however
due to the fact that women are at greater risk for devel-
oping Alzheimer’s Disease [93] and the number of
women living in long-term care facilities in Belgium is
higher [94]. Sixth, no long-term follow-up was con-
ducted. Seventh, we did not include a physically active
control condition such as a combined aerobic, balance,
and strength training program. Eighth, we did not con-
trol for the effect of concurrent medication use includ-
ing for example cholinesterase inhibitors, memantine,
typical and atypical antipsychotics, antidepressants, and
benzodiazepines, although it is known they may act as
potential confounders and disruptors in MNCD trials
[95].
Conclusion
In conclusion, the present pilot RCT demonstrates that
an individually adapted exergame training program im-
proves lower extremity functioning, cognitive function,
and step reaction time and reduces symptoms of depres-
sion in a sample of multi-morbid older adults with
MNCD. Moreover, the adherence rates and lack of ad-
verse events indicate that exergaming is an effective
strategy for motivating people with MNCD dwelling in a
nursing home to be physically active.
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